Professor, Medicine, University of Arizona College of Medicine
Endocrinology
Dr. Peter D. Reaven, MD
|
|
Give Review
Peter Reaven is an expert in the field of Endocrinology. He went to University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10 in research and 19 in primary care medicine Peter Reaven is also a published doctor. He has 100 paper published. The most recent paper is: LDL isolated from Greek subjects on a typical diet or from American subjects on an oleate-supplemented diet induces less monocyte chemotaxis and adhesion when exposed ...
Publications
- A Link Between Hypoglycemia and Progression of Atherosclerosis in the Veterans Affairs Diabetes Trial (VADT).
- Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants.
- Exenatide Protects against Glucose and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans.
- Dietary models of insulin resistance.
- The effect of intensive glucose lowering therapy among major racial/ethnic groups in the veterans affairs diabetes trial.
- A Novel Insulin Resistance Index to Monitor Changes in Insulin Sensitivity and Glucose Tolerance: the ACT NOW Study.
- Adipose and leptomeningeal arteriole endothelial dysfunction induced by β-amyloid peptide: A practical human model to study Alzheimer's disease vasculopathy.
- p38α mitogen-activated kinase mediates cardiomyocyte apoptosis induced by palmitate.
- Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOW.
- Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes.
- Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT).
- Association of PAI-1 and Fibrinogen with Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT).
- Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High Risk.
- Prevention of Diabetes with Pioglitazone in Act Now: Physiologic Correlates.
- Effect of Pioglitazone on Body Composition and Bone Density in Subjects with Prediabetes in the ACT NOW Trial.
- Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors.
- A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance.
- Progression of Vascular Calcification Is Increased With Statin Use in the Veterans Affairs Diabetes Trial (VADT).
- Beyond Glycemic Control: Incretins and Cardiovascular Protection in Diabetes.
- Does Aggressive Glycemic Control Benefit Macrovascular and Microvascular Disease in Type 2 Diabetes?: Insights from ACCORD, ADVANCE, and VADT.
- Intensive glycemic control and cardiovascular disease: are there patients who may benefit?
- Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis.
- Postprandial Hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins.
- Fetuin-A does not explain ethnic disparity in cardiometabolic risk factors and subclinical atherosclerosis between Hispanics and non-Hispanic whites.
- Improvement of postprandial endothelial function after a single dose of exenatide in individuals with impaired glucose tolerance and recent-onset type 2 diabetes.
- Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation.
- Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages.
- Pioglitazone inhibits the expression of inflammatory cytokines from both monocytes and lymphocytes in patients with impaired glucose tolerance.
- Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women.
- Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation.
- The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers.
- Molecular and signaling mechanisms of atherosclerosis in insulin resistance.
- Macrophage-secreted factors induce adipocyte inflammation and insulin resistance.
- Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric comp...
- Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications.
- Exercise training is not associated with improved levels of C-reactive protein or adiponectin.
- Cardiovascular risk factors associated with insulin resistance in children persist into late adolescence.
- Discrimination between obesity and insulin resistance in the relationship with adiponectin.
- Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women.
- Comparison of frequency of coronary artery calcium in healthy Hispanic versus non-Hispanic white men by electron beam computed tomography.
- Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and non...
- Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.
- Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes.
- Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.
- Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol.
- Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.
- Gas chromatographic method using photoionization detection for the determination of breath pentane.
- Effect of antioxidants alone and in combination with monounsaturated fatty acid-enriched diets on lipoprotein oxidation.
- Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor...
- Cardiovascular disease insulin risk in Mexican-American and Anglo-American children and mothers.
- Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassay.
- Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans.
- Lovastatin, nicotinic acid, and rhabdomyolysis.
- Dietary and pharmacologic regimens to reduce lipid peroxidation in non-insulin-dependent diabetes mellitus.
- Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects.
- Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low de...
- Oxidized low density lipoproteins in atherogenesis: role of dietary modification.
- Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene.
- Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha-tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility to oxidation.
- Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM.
- Mechanisms of atherosclerosis: role of LDL oxidation.
- Susceptibility of human LDL to oxidative modification. Effects of variations in beta-carotene concentration and oxygen tension.
- Studies on the ability of dietary supplementation with beta-carotene to protect low-density lipoprotein from oxidative modification.
- Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modificatio...
- Effect of age on glucose oxidation by isolated rat islets.
- Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.
- Relation between leisure-time physical activity and blood pressure in older women.
- Abnormal glucose tolerance and hypertension.
- Leisure time exercise and lipid and lipoprotein levels in an older population.
- Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes.
- Liposomes enriched in oleic acid are less susceptible to oxidation and have less proinflammatory activity when exposed to oxidizing conditions.
- The role of dietary fatty acids in lipoprotein oxidation and atherosclerosis.
- LDL isolated from Greek subjects on a typical diet or from American subjects on an oleate-supplemented diet induces less monocyte chemotaxis and adhesion when exposed ...
- Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsuline...
- All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor a...
- Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis.
- Lipoprotein modification and atherosclerosis in aging.
- Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors.
- Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.
- Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL.
- Managing lipid disorders: further evaluation of the VA-HIT.
- Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
- Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT).
- Actos Now for the prevention of diabetes (ACT NOW) study.
- Serum amyloid a truncations in type 2 diabetes mellitus.
- Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.
- Preliminary report: hepatic fat and inflammation in type 2 diabetes mellitus.
- Glucose control and vascular complications in veterans with type 2 diabetes.
- Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT).
- Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT).
- Autoantibodies to oxidized LDL and cardiovascular risk: the Framingham Offspring Study.
- Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes.
- Reduced coronary artery and abdominal aortic calcification in Hispanics with type 2 diabetes.
- The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial.
- Pioglitazone for diabetes prevention in impaired glucose tolerance.
- Metabolic syndrome.
- Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells.
- Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the Americ...
- Disialylated Apolipoprotein C-III Proteoform is Associated with Improved Lipids in Prediabetes and Type 2 Diabetes.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Conditions Treated
- Hyperlipidemia
- Hyperparathyroidism
- Osteopenia
Doctors Specialties
- Endocrinology
Accepted Insurances
Education
-
University of California San Diego -
University of Chicago Pritzker School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Lory E. Baraz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan A. Krakoff, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James A. Deer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marie S. Thearle, MD
This Doctor is OpenDoctor Recommended.
|